Prioritising the most needed paediatric antiretroviral formulations: the PADO4 listMartina Penazzato, Victor Musiime, Anna Turkova et al.|The Lancet HIV|2019Cited by 61
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defectsLynne Mofenson, Nathan Ford, Anton Pozniak et al.|Journal of the International AIDS Society|2019Cited by 43
Analysis of Pharmacovigilance Databases for Dolutegravir Safety in PregnancyNikolien S van De Ven, Andrew Hill, Anton Pozniak et al.|Clinical Infectious Diseases|2019Cited by 37
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic reviewTom Jacobs, Nandita Sugandhi, Elin M. Svensson et al.|Journal of Antimicrobial Chemotherapy|2020Cited by 32